Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways - PubMed (original) (raw)
Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways
Ning Zhang et al. Regul Toxicol Pharmacol. 2020 Feb.
Abstract
Berberine has been found to exhibit an array of pharmacological activities relating to the lowering of blood glucose and the treatment of polycystic ovarian syndrome (PCOS). The mechanism underlying these activites, however, is poorly understood. In the present study, female Sprague-Dawley (SD) rats were given oral letrozole to establish a model of insulin-resistant PCOS, and animals were then randomized into untreated or berberine-treated groups (400, 200, or 100 mg/kg). After 28 days, we measured homeostasis model assessment of insulin resistance (HOMA-IR) and insulin sensitivity index (ISI) values in these animals. We further conducted H&E staining of ovarian tissues, assessed mRNA expression of glucose transporter 4 (GLUT4) via real time PCR, and used Western blotting to measure GLUT4 and PI3K/AKT and MAPK pathway protein levels. Berberine treatment was able to help restore HOMA-IR and ISI values to normal levels while simultaneously bolstering the expression of GLUT4. Normal ovarian morphology was also restored upon berberine treatment. We further found that 400 mg/kg berberine treatment was associated with activation of PI3K/AKT signaling and suppression of the MAPK pathway. In conclusion, berberine has the potential to reduce PCOS pathology and IR values in a rat model system through a mechanism linked to GLUT4 upregulation via PI3K/AKT activation and MAPK pathway suppression.
Keywords: Berberine; Glucose transporter 4 (GLUT4); Insulin resistance (IR); MAPK pathway; PI3K/AKT pathway; Polycystic ovary syndrome (PCOS).
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
- Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z, Dong J, Xue C, Li X, Liu K, Liu B, Cheng J, Huang F. Qiu Z, et al. J Ethnopharmacol. 2020 Mar 25;250:111965. doi: 10.1016/j.jep.2019.111965. Epub 2019 Jun 8. J Ethnopharmacol. 2020. PMID: 31185267 - Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.
Yu J, Ding C, Hua Z, Jiang X, Wang C. Yu J, et al. J Obstet Gynaecol Res. 2021 May;47(5):1789-1803. doi: 10.1111/jog.14730. Epub 2021 Mar 11. J Obstet Gynaecol Res. 2021. PMID: 33709493 Free PMC article. - Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet.
Peng MF, Tian S, Song YG, Li CX, Miao MS, Ren Z, Li M. Peng MF, et al. J Ethnopharmacol. 2021 Jun 12;273:113947. doi: 10.1016/j.jep.2021.113947. Epub 2021 Feb 19. J Ethnopharmacol. 2021. PMID: 33617969 - Effect and mechanism of berberine against polycystic ovary syndrome.
Zhang SW, Zhou J, Gober HJ, Leung WT, Wang L. Zhang SW, et al. Biomed Pharmacother. 2021 Jun;138:111468. doi: 10.1016/j.biopha.2021.111468. Epub 2021 Mar 16. Biomed Pharmacother. 2021. PMID: 33740526 Review. - Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway.
Tong C, Wu Y, Zhang L, Yu Y. Tong C, et al. Front Endocrinol (Lausanne). 2022 Dec 16;13:1091147. doi: 10.3389/fendo.2022.1091147. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36589825 Free PMC article. Review.
Cited by
- LncRNA PKD1P6 modulates ovarian granulosa cell survival of hyperandrogenic polycystic ovary syndrome by targeting miR-135b-5p and inhibiting ERK1/2 signaling.
Zhou W, Lian Y, Chen J, Zhang T, Zhang W, Huang R, Yang M, Yan X, Chen Q. Zhou W, et al. Heliyon. 2024 Aug 14;10(16):e36321. doi: 10.1016/j.heliyon.2024.e36321. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39253226 Free PMC article. - Role of bariatric surgery in improving diabetic cardiomyopathy: Molecular mechanisms and therapeutic perspectives (Review).
Song K, Liang D, Xiao D, Kang A, Ren Y. Song K, et al. Mol Med Rep. 2024 Nov;30(5):199. doi: 10.3892/mmr.2024.13323. Epub 2024 Sep 6. Mol Med Rep. 2024. PMID: 39239741 Free PMC article. Review. - Protective effects of vanillic acid on letrozole-induced polycystic ovarian syndrome: A comprehensive study in female wistar rats.
V Gadhave P, V Sutar G, Sajane SJ, Redasani VK, Das K, Prasad P D, Alobid S, Ibrahim Almoteer A, Imam Rabbani S, Yasmin F, Gilkaramenthi R, Abdulrazaq AlAnazi M, Jameel Alshamrani H, Asdaq SMB. V Gadhave P, et al. Saudi Pharm J. 2024 Feb;32(2):101953. doi: 10.1016/j.jsps.2024.101953. Epub 2024 Jan 9. Saudi Pharm J. 2024. PMID: 38288132 Free PMC article. - Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): A Multifaceted Hypothesis Towards the Disease with Potential Therapeutics.
Nisa KU, Tarfeen N, Mir SA, Waza AA, Ahmad MB, Ganai BA. Nisa KU, et al. Indian J Clin Biochem. 2024 Jan;39(1):18-36. doi: 10.1007/s12291-023-01130-7. Epub 2023 Mar 18. Indian J Clin Biochem. 2024. PMID: 38223007 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical